Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 13

1.

Proliferative activity of intratumoral CD8(+) T-lymphocytes as a prognostic factor in human renal cell carcinoma: clinicopathologic demonstration of antitumor immunity.

Nakano O, Sato M, Naito Y, Suzuki K, Orikasa S, Aizawa M, Suzuki Y, Shintaku I, Nagura H, Ohtani H.

Cancer Res. 2001 Jul 1;61(13):5132-6.

2.

[Cytotoxic T lymphocytes: role in immunosurveillance and in immunotherapy].

Benchetrit F, Gazagne A, Adotevi O, Haicheur N, Godard B, Badoual C, Fridman WH, Tartour E.

Bull Cancer. 2003 Aug-Sep;90(8-9):677-85. Review. French.

3.

[Paraneoplastic nephropathy associated with adult renal carcinoma (immunologic and clinicopathologic study)].

Kiss B, Magyarlaki T, Buzogány I, Fazekas A, Sükösd F, Nagy J.

Orv Hetil. 1999 Jan 10;140(2):75-80. Review. Hungarian.

PMID:
9949663
4.

CD20+ B cells: the other tumor-infiltrating lymphocytes.

Nelson BH.

J Immunol. 2010 Nov 1;185(9):4977-82. doi: 10.4049/jimmunol.1001323. Review.

6.
7.

Tumor-infiltrating cells and their possible prognostic significance.

Pastrnák A, Jansa P.

Acta Univ Palacki Olomuc Fac Med. 1989;124:7-71. Review.

PMID:
2530850
8.

Prognostic and predictive impact of intra- and peritumoral immune infiltrates.

Fridman WH, Galon J, Pagès F, Tartour E, Sautès-Fridman C, Kroemer G.

Cancer Res. 2011 Sep 1;71(17):5601-5. doi: 10.1158/0008-5472.CAN-11-1316. Epub 2011 Aug 16. Review.

9.

The intriguing role of polymorphonuclear neutrophils in antitumor reactions.

Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A, Musiani P.

Blood. 2001 Jan 15;97(2):339-45. Review. No abstract available.

10.

Tumor-infiltrating immune cells and prognosis: the potential link between conventional cancer therapy and immunity.

Jochems C, Schlom J.

Exp Biol Med (Maywood). 2011 May 1;236(5):567-79. doi: 10.1258/ebm.2011.011007. Epub 2011 Apr 12. Review.

11.

Metabolic Control of CD8+ T Cell Fate Decisions and Antitumor Immunity.

Zhang L, Romero P.

Trends Mol Med. 2018 Jan;24(1):30-48. doi: 10.1016/j.molmed.2017.11.005. Epub 2017 Dec 12. Review.

PMID:
29246759
12.

The Progress of T Cell Immunity Related to Prognosis in Gastric Cancer.

Wei M, Shen D, Mulmi Shrestha S, Liu J, Zhang J, Yin Y.

Biomed Res Int. 2018 Feb 27;2018:3201940. doi: 10.1155/2018/3201940. eCollection 2018. Review.

13.

Hypoxia and antitumor CD8+ T cells: An incompatible alliance?

Vuillefroy de Silly R, Dietrich PY, Walker PR.

Oncoimmunology. 2016 Sep 9;5(12):e1232236. doi: 10.1080/2162402X.2016.1232236. eCollection 2016. Review.

Supplemental Content

Support Center